https://finance.yahoo.com/news/pfizer-pfe-stock-rises-fda-152800173.html
0
0
12/19/23 at 7:28am
Organization
Yahoo Entertainment
Author
Zacks Equity Research
39 words
0
Comments
The FDA approves Pfizer's (PFE) Padcev in combination with Merck's (MRK) Keytruda for adult patients with advanced bladder cancer. Stock rises 1.6%.
You are the first to view
Create an account
or login to join the discussion